[THE INVESTOR] Braman Investment said on Jan.18 that it has invested 10 billion won (US$9.30 million) in Korean biotech firm Neuracle Science, which develops treatment for neurodegenerative disorders ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Emerging choroidal neovascularization gene therapies, such as surabgene lomparvovec (ABBV-RGX-314) by AbbVie/REGENXBIO, NG101 by Neuracle Genetics, and Ixoberogene soroparvovec by Adverum ...
Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...
A Chinese start-up has started testing what it calls a "micro-invasive" brain-computer interface (BCI) in pigs, and monkeys are next, making the company one of China's leaders in this emerging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback